寵物用癌症治療的全球市場 - 產業規模，佔有率，趨勢，機會，預測:各治療法，各動物類型，各癌症類型，各企業，各地區(2017年～2027年)

全球寵物用癌症治療的市場規模，預計在預測期間內的2023年～2027年達成驚人的成長。

市場成長的主要原因，是對寵物健康的意識高漲，和動物的癌症發病率增加。還有市場成長的其他的因素，是擁有的寵物率、動物飼養數的擴大，診斷技術的進步，研究開發舉措增加等。再加上寵物的腫瘤學治療對管理相關研究開發活動的高額的投資，預計今後數年提供向市場企業有利的機會。

本報告提供全球寵物用癌症治療市場相關調查分析，各市場區隔、各地區的市場規模、佔有率預測，市場動態，企業簡介等系統性資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 COVID-19對全球寵物用癌症治療市場的影響

第5章 VOC(客戶的迴響)

第6章 全球寵物用癌症治療市場展望

• 市場規模與預測
  • 各金額
• 市場佔有率與預測
  • 各治療法(手術，放射線治療，化療，免疫療法，其他)
  • 各動物類型(狗，貓，其他)
  • 各癌症類型(淋巴瘤，肥胖細胞癌症，乳腺、扁平表皮癌症，其他)
  • 各企業(2021年)
  • 各地區
• 市場地圖

第7章 北美的寵物用癌症治療市場展望

• 市場規模與預測
  • 各金額
• 市場佔有率與預測
  • 各治療法
  • 各動物類型
  • 各癌症類型
  • 各國
• 北美:各國分析
  • 美國
  • 墨西哥
  • 加拿大

第8章 歐洲的寵物用癌症治療市場展望

• 市場規模與預測
  • 各金額
• 市場佔有率與預測
  • 各治療法
  • 各動物類型
  • 各癌症類型
  • 各國
• 歐洲:各國分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第9章 亞太地區的寵物癌症治療市場展望

• 市場規模與預測
  • 各金額
• 市場佔有率與預測
  • 各治療法
  • 各動物類型
  • 各癌症類型
  • 各國
• 亞太地區:各國分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第10章 南美的寵物用癌症治療市場展望

• 市場規模與預測
  • 各金額
• 市場佔有率與預測
  • 各治療法
  • 各動物類型
  • 各癌症類型
  • 各國
• 南美:各國分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第11章 中東、非洲的寵物用癌症治療市場展望

• 市場規模與預測
  • 各金額
• 市場佔有率與預測
  • 各治療法
  • 各動物類型
  • 各癌症類型
  • 各國
• MEA:各國分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 埃及
  • 土耳其

第12章 市場動態

• 促進因素
• 課題

第13章 市場趨勢與開發

第14章 競爭情形

• C.H. Boehringer Sohn Ko. KG
• ELIAS Animal Health, LLC
• Zoetis Inc.
• AB Science S.A.
• Karyopharm Therapeutics, Inc.
• Vivesto AB
• Merial Inc.
• Elanco Animal Health, Inc.
• Dechra Pharmaceuticals PLC(Anivive Lifesciences)
• Torigen Pharmaceuticals Inc.

第15章 策略性建議

The global pet cancer therapeutics market is anticipated to observe an impressive growth during the forecast period, 2023-2027. The major factors include growing consciousness of pet's health and increasing incidences of cancer among animals. Cancer in pets is one of the primary reasons for death, globally. Nowadays, pets have better chances to get diagnosed with cancer due which early adoption of treatment plans are required, which bolster the growth of the market. The other factors supporting the market's growth are rise in pet ownership or animal adoption, advancement in diagnostic techniques and rise in R&D initiatives. Additionally, heavy investments in research and development activities coupled with oncology treatment and management in pets offers lucrative opportunities to the market players in upcoming years.

Increasing Awareness regarding Pet Healthcare and Treatments

The increasing domestication of animals and growing concerns regarding pet health among the people are supporting the market growth. In 2021, number of pet dogs owned worldwide was 471 million. People are becoming more thoughtful about their pet's health and are expending generously on the best available animal therapeutics. Average American yearly spending on pet dogs is estimated to be USD 1201. In addition, growing pet's health awareness programs is augmenting the growth of the market. For instance, the Blue Buffalo Foundation and the Pet Cancer Awareness Program (PCA) are some initiatives which raise awareness and provide information to the pet parents.

Increasing Prevalence of Cancer

The growing prevalence of cancer among pet animals, is a contributing factor for the growth of the market. Cancer is one of the key causes of death in pets, mostly in dogs that are older than 10 years. According to the Veterinary Cancer Society, in 2017, cancer was the foremost cause of death in 47% of dogs, especially those that are over the age of 10, and 32% of cats. Leukemia and lymphoma are very common cancer in cats and certain breeds of elderly dogs. In 2017, Animal Cancer Foundation published a study, which revealed approximately around 25% of all dogs will develop a tumor at some point in their life.

Technological Advancements

Various technological advancements, such as the development of highly targeted and specific cures for animal cancer treatment with minimal side effects, are also supporting the market growth. Increasing R&D initiatives for cancer management is propelling the market growth, as various anti-cancer therapies are launching for veterinary cancer treatment. For instance, in 2017, Jackson Laboratory launched Tallwood Canine Cancer Research Initiative (TCCRI), to generate a biobank of dog tumors for giving insights on cancer cure through research. Also, organizations such as Animal Cancer Foundation, Veterinary Cancer Society, Petco Foundation and PetCure Oncology are doing oncology research such as canine cancer genome project to gain the knowledge related to the genetic makeup of cancer tumors in animals. The foremost focus is on the development of anticancer drugs and improvising their effectiveness and reducing their toxic effects on the pet's body.

Market Segmentation

The global pet cancer therapeutics market is segmented into therapy, animal type, cancer type, and company. Based on therapy, the market is divided into surgery, radiotherapy, chemotherapy, immunotherapy, and others. Based on animal type, the market is divided into canine, feline, and others. Based on cancer type, the market is segmented into lymphoma, mast cell cancer, mammary & squamous cell cancer, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising domestication and rise in the occurrence of pet cancers in the country.

Market Players

C.H. Boehringer Sohn Ko. KG, ELIAS Animal Health, LLC, Zoetis Inc., AB Science S.A., Karyopharm Therapeutics, Inc., Vivesto AB, Merial Inc., Elanco Animal Health, Inc., Dechra Pharmaceuticals PLC (Anivive Lifesciences), and Torigen Pharmaceuticals Inc. are some of the leading companies operating in the market.

Report Scope:

In this report, global pet cancer therapeutics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Pet Cancer Therapeutics Market, By Therapy:

• Surgery
• Radiotherapy
• Chemotherapy
• Immunotherapy
• Others

Pet Cancer Therapeutics Market, By Animal Type:

• Canine
• Feline
• Others

Pet Cancer Therapeutics Market, By Cancer Type:

• Lymphoma
• Mast Cell Cancer
• Mammary & Squamous Cell Cancer
• Others

Pet Cancer Therapeutics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea

• Europe & CIS
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Pet Cancer Therapeutics Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Pet Cancer Therapeutics Market

5. Voice of Customer

6. Global Pet Cancer Therapeutics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Therapy (Surgery, Radiotherapy, Chemotherapy, Immunotherapy, Others)
  • 6.2.2. By Animal Type (Canine, Feline, Others)
  • 6.2.3. By Cancer Type (Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer, Others)
  • 6.2.4. By Company (2021)
  • 6.2.5. By Region
• 6.3. Market Map

7. North America Pet Cancer Therapeutics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Therapy
  • 7.2.2. By Animal Type
  • 7.2.3. By Cancer Type
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Pet Cancer Therapeutics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Therapy
      • 7.3.1.2.2. By Animal Type
      • 7.3.1.2.3. By Cancer Type
  • 7.3.2. Mexico Pet Cancer Therapeutics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Therapy
      • 7.3.2.2.2. By Animal Type
      • 7.3.2.2.3. By Cancer Type
  • 7.3.3. Canada Pet Cancer Therapeutics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Therapy
      • 7.3.3.2.2. By Animal Type
      • 7.3.3.2.3. By Cancer Type

8. Europe Pet Cancer Therapeutics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Therapy
  • 8.2.2. By Animal Type
  • 8.2.3. By Cancer Type
  • 8.2.4. By Country
• 8.3. Europe: Country Analysis
  • 8.3.1. France Pet Cancer Therapeutics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Therapy
      • 8.3.1.2.2. By Animal Type
      • 8.3.1.2.3. By Cancer Type
  • 8.3.2. Germany Pet Cancer Therapeutics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Therapy
      • 8.3.2.2.2. By Animal Type
      • 8.3.2.2.3. By Cancer Type
  • 8.3.3. United Kingdom Pet Cancer Therapeutics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Therapy
      • 8.3.3.2.2. By Animal Type
      • 8.3.3.2.3. By Cancer Type
  • 8.3.4. Italy Pet Cancer Therapeutics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Therapy
      • 8.3.4.2.2. By Animal Type
      • 8.3.4.2.3. By Cancer Type
  • 8.3.5. Spain Pet Cancer Therapeutics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Therapy
      • 8.3.5.2.2. By Animal Type
      • 8.3.5.2.3. By Cancer Type

9. Asia-Pacific Pet Cancer Therapeutics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Therapy
  • 9.2.2. By Animal Type
  • 9.2.3. By Cancer Type
  • 9.2.4. By Country
• 9.3. Asia-Pacific: Country Analysis
  • 9.3.1. China Pet Cancer Therapeutics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Therapy
      • 9.3.1.2.2. By Animal Type
      • 9.3.1.2.3. By Cancer Type
  • 9.3.2. India Pet Cancer Therapeutics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Therapy
      • 9.3.2.2.2. By Animal Type
      • 9.3.2.2.3. By Cancer Type
  • 9.3.3. Japan Pet Cancer Therapeutics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Therapy
      • 9.3.3.2.2. By Animal Type
      • 9.3.3.2.3. By Cancer Type
  • 9.3.4. South Korea Pet Cancer Therapeutics Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Therapy
      • 9.3.4.2.2. By Animal Type
      • 9.3.4.2.3. By Cancer Type
  • 9.3.5. Australia Pet Cancer Therapeutics Market Outlook
    • 9.3.5.1. Market Size & Forecast
      • 9.3.5.1.1. By Value
    • 9.3.5.2. Market Share & Forecast
      • 9.3.5.2.1. By Therapy
      • 9.3.5.2.2. By Animal Type
      • 9.3.5.2.3. By Cancer Type

10. South America Pet Cancer Therapeutics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Therapy
  • 10.2.2. By Animal Type
  • 10.2.3. By Cancer Type
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Pet Cancer Therapeutics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Therapy
      • 10.3.1.2.2. By Animal Type
      • 10.3.1.2.3. By Cancer Type
  • 10.3.2. Argentina Pet Cancer Therapeutics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Therapy
      • 10.3.2.2.2. By Animal Type
      • 10.3.2.2.3. By Cancer Type
  • 10.3.3. Colombia Pet Cancer Therapeutics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Therapy
      • 10.3.3.2.2. By Animal Type
      • 10.3.3.2.3. By Cancer Type

11. Middle East and Africa Pet Cancer Therapeutics Market Outlook

• 11.1. Market Size & Forecast
  • 11.1.1. By Value
• 11.2. Market Share & Forecast
  • 11.2.1. By Therapy
  • 11.2.2. By Animal Type
  • 11.2.3. By Cancer Type
  • 11.2.4. By Country
• 11.3. MEA: Country Analysis
  • 11.3.1. South Africa Pet Cancer Therapeutics Market Outlook
    • 11.3.1.1. Market Size & Forecast
      • 11.3.1.1.1. By Value
    • 11.3.1.2. Market Share & Forecast
      • 11.3.1.2.1. By Therapy
      • 11.3.1.2.2. By Animal Type
      • 11.3.1.2.3. By Cancer Type
  • 11.3.2. Saudi Arabia Pet Cancer Therapeutics Market Outlook
    • 11.3.2.1. Market Size & Forecast
      • 11.3.2.1.1. By Value
    • 11.3.2.2. Market Share & Forecast
      • 11.3.2.2.1. By Therapy
      • 11.3.2.2.2. By Animal Type
      • 11.3.2.2.3. By Cancer Type
  • 11.3.3. UAE Pet Cancer Therapeutics Market Outlook
    • 11.3.3.1. Market Size & Forecast
      • 11.3.3.1.1. By Value
    • 11.3.3.2. Market Share & Forecast
      • 11.3.3.2.1. By Therapy
      • 11.3.3.2.2. By Animal Type
      • 11.3.3.2.3. By Cancer Type
  • 11.3.4. Egypt Pet Cancer Therapeutics Market Outlook
    • 11.3.4.1. Market Size & Forecast
      • 11.3.4.1.1. By Value
    • 11.3.4.2. Market Share & Forecast
      • 11.3.4.2.1. By Therapy
      • 11.3.4.2.2. By Animal Type
      • 11.3.4.2.3. By Cancer Type
  • 11.3.5. Turkey Pet Cancer Therapeutics Market Outlook
    • 11.3.5.1. Market Size & Forecast
      • 11.3.5.1.1. By Value
    • 11.3.5.2. Market Share & Forecast
      • 11.3.5.2.1. By Therapy
      • 11.3.5.2.2. By Animal Type
      • 11.3.5.2.3. By Cancer Type

12. Market Dynamics

• 12.1. Drivers
• 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

• 14.1. C.H. Boehringer Sohn Ko. KG
• 14.2. ELIAS Animal Health, LLC
• 14.3. Zoetis Inc.
• 14.4. AB Science S.A.
• 14.5. Karyopharm Therapeutics, Inc.
• 14.6. Vivesto AB
• 14.7. Merial Inc.
• 14.8. Elanco Animal Health, Inc.
• 14.9. Dechra Pharmaceuticals PLC (Anivive Lifesciences)
• 14.10. Torigen Pharmaceuticals Inc.

15. Strategic Recommendations